Vycor Medical (VYCO) EV to FCF (2013 - 2026)

Vycor Medical (VYCO) has reported EV to FCF for 14 consecutive years, with 449.55 the latest figure, recorded in Q2 2026.

• On a quarterly basis, EV to FCF fell 594.58% year-over-year to 449.55 in Q2 2026; TTM through Jun 2026 was 36.42, a 106.95% increase from a year earlier, with the FY2025 full-year figure at 209.56, down 614.35% from the prior year.
• EV to FCF was 449.55 for Q2 2026 at Vycor Medical, down from 28.46 in the prior quarter.
• Over five years, EV to FCF peaked at 1532.98 in Q1 2024 and troughed at 6447.01 in Q4 2023.
• A 5-year average of 291.9 and a median of 42.25 in 2022 frame the typical range for EV to FCF.
• Across the five-year window, EV to FCF plunged 7267.73% in 2023 and soared 1210.7% in 2024, its largest moves.
• Over 5 years, EV to FCF stood at 87.5 in 2022, then sank by 7267.73% to 6447.01 in 2023, then surged by 99.1% to 58.27 in 2024, then soared by 278.69% to 104.12 in 2025, then plunged by 531.76% to 449.55 in 2026.
• The last three EV to FCF figures came in at 449.55 (Q2 2026), 28.46 (Q1 2026), and 104.12 (Q4 2025), per Business Quant data.